Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026

These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies.Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC.Launch Date/Release: June 3, 2026Expiration Date: May 31, 2027FACULTYKris V. Kowdley, MD, AGAF, FAASLD, FACG, FACPLiver Institute NorthwestDirector, Velocity Clinical ResearchMedical Director and Senior Scientific AdvisorWashington State UniversityElson S. Floyd College of Medicine – ProfessorThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.